Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Treatment by Aleksandra Norwicka
Introduction
Aleksandra Norwicka is an accomplished inventor based in Nowicka, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of T cell therapies. Her work focuses on expanding and activating γδ T cells, which play a crucial role in the immune response against cancer.
Latest Patents
Norwicka holds a patent titled "Methods for expanding and activating γδ T cells for the treatment of cancer and related malignancies." This patent outlines methods for the expansion and activation of T cells, specifically γδ T cells, which can be utilized for transgene expression. The disclosure also addresses the depletion of α- and/or β-TCR positive cells during the process. The T cell populations described in her patent comprise expanded γδ T cells and reduced α- and/or β-TCR positive cells, providing new avenues for cancer treatment.
Career Highlights
Throughout her career, Norwicka has demonstrated a commitment to advancing cancer therapies. Her innovative approaches have positioned her as a leader in the field of immunotherapy. She is currently associated with Immatics US, Inc., where she continues to develop groundbreaking treatments for cancer patients.
Collaborations
Norwicka collaborates with talented professionals in her field, including Monique Dao and Steffen Walter. These partnerships enhance her research efforts and contribute to the development of effective cancer therapies.
Conclusion
Aleksandra Norwicka's work in expanding and activating γδ T cells represents a significant advancement in cancer treatment. Her innovative patent and collaborations with esteemed colleagues underscore her dedication to improving patient outcomes.